CEFAMANDOLE NAFATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for cefamandole nafate and what is the scope of freedom to operate?
Cefamandole nafate
is the generic ingredient in one branded drug marketed by Lilly and is included in two NDAs. Additional information is available in the individual branded drug profile pages.There are three drug master file entries for cefamandole nafate.
Summary for CEFAMANDOLE NAFATE
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 2 |
| Drug Master File Entries: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 83 |
| Patent Applications: | 2,785 |
| DailyMed Link: | CEFAMANDOLE NAFATE at DailyMed |
Medical Subject Heading (MeSH) Categories for CEFAMANDOLE NAFATE
Anatomical Therapeutic Chemical (ATC) Classes for CEFAMANDOLE NAFATE
US Patents and Regulatory Information for CEFAMANDOLE NAFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly | MANDOL | cefamandole nafate | INJECTABLE;INJECTION | 062560-001 | Sep 10, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lilly | MANDOL | cefamandole nafate | INJECTABLE;INJECTION | 050504-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lilly | MANDOL | cefamandole nafate | INJECTABLE;INJECTION | 050504-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lilly | MANDOL | cefamandole nafate | INJECTABLE;INJECTION | 062560-002 | Sep 10, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lilly | MANDOL | cefamandole nafate | INJECTABLE;INJECTION | 050504-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
